強気
$10.69
シナリオ価格
$9.810
-0.177 (-1.80%)終値時点
Orthofix Medical Inc. is a global medical technology company. It offers a comprehensive portfolio of spinal hardware, bone growth therapies, limb reconstruction solutions, biologics and enabling technologies, including the 7D FLASH Navigation System. Its Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. It provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. It offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market that encompasses four pillars: deformity correction, limb lengthening, complex fracture management, and limb preservation.
Orthofix Medical Inc is currently a hold. The stock is priced at $9.81, with a recent RSI of 60.256 indicating it's nearing overbought territory. The forward P/E ratio is extremely high at 500, suggesting that the stock is overvalued based on future earnings expectations. Additionally, the company has seen a significant year-to-date decline of 33.89%, which raises concerns about its recovery potential. While there was a positive 5-day change of 4.58%, the overall trend remains negative, and the recent investigation into fiduciary breaches could pose further risks.
Canaccord
$13
2026-08-10
Canaccord
2026-08-10
目標株価
$13
Barrington
$14
2026-08-06
Barrington
2026-08-06
目標株価
$14
Stifel
$13
2026-08-05
Stifel
2026-08-05
目標株価
$13
Stifel
$18
2026-03-09
Stifel
2026-03-09
目標株価
$18
Canaccord
$20
2026-02-26
Canaccord
2026-02-26
目標株価
$20
シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

Levi & Korsinsky Investigates Orthofix Medical for Fiduciary Breaches

Halper Sadeh LLC Investigates Orthofix Management for Breach of Duties

Orthofix Medical Inc. Under Investigation for Fiduciary Breaches

Orthofix Medical Q2 2026 Earnings Call Insights

Orthofix Medical Reports Q2 Earnings Beat but Shares Drop
Orthofix Medical Inc. is a global medical technology company. It offers a comprehensive portfolio of spinal hardware, bone growth therapies, limb reconstruction solutions, biologics and enabling technologies, including the 7D FLASH Navigation System. Its Global Spine segment offers two primary product categories: bone growth therapies and spinal implants, biologics, and enabling technologies. It provides implantable medical devices, biologics, enabling technologies, and other regenerative solutions which aim to restore the quality of life of patients suffering from diseases and traumas of the spine. It offers a variety of treatment solutions that incorporate multiple treatment modalities, such as mechanical, biological, and electromagnetic modes. Its Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market that encompasses four pillars: deformity correction, limb lengthening, complex fracture management, and limb preservation. It operates in the Healthcare sector (SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry).
Orthofix Medical Inc is currently a hold. The stock is priced at $9.81, with a recent RSI of 60.256 indicating it's nearing overbought territory. The forward P/E ratio is extremely high at 500, suggesting that the stock is overvalued based on future earnings expectations. Additionally, the company has seen a significant year-to-date decline of 33.89%, which raises concerns about its recovery potential. While there was a positive 5-day change of 4.58%, the overall trend remains negative, and the recent investigation into fiduciary breaches could pose further risks.
7 analysts cover OFIX: 6 rate it Buy, 1 Hold and 0 Sell. The average price target is 21.33.
投稿はまだありません
登録またはログインして議論に参加本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。